$BFRI FDA Approves Use of Up To Three Tubes of Biofrontera’s Ameluz (aminolevulinic acid HCI) Topical Gel, 10% In One Treatment
And the market continues to open....
https://t.co/tsfbVmO2km
$BFRI Biofrontera gets FDA approval to increase the maximally approved dosage of Ameluz from one to three tubes for treatment of actinic keratoses. https://t.co/A2riRhSRmC